K. Hanada and K. Kobayashi, “Invariant natural killer T cell–based immunotherapy using alpha-galactosylceramide–pulsed CD14+ monocytes for advanced gallbladder cancer”, EJCRIM, vol. 13, no. 8, Jul. 2026, doi: 10.12890/2026_007198.